Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AXON ENTERPRISE, INC.AXON · Entity 567 | Director · CHIEF EXECUTIVE OFFICER | September 08, 2026 | September 10, 2026 |
| Insight Molecular Diagnostics Inc.OCX · Entity 6631 | 10% owner | February 07, 2025 | February 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AXON ENTERPRISE, INC.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,118,012 |
Ending reported balance
After 2026-09-08 transaction · row 11
11 source rows · reconciled sequenceRow 1 · 2026-09-08 · Sale · Disposed 71 · Balance 3,127,941 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. Row 2 · 2026-09-08 · Sale · Disposed 410 · Balance 3,127,531 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F2: The transaction was executed in multiple trades at prices ranging from $503.46 to $504.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2026-09-08 · Sale · Disposed 1,104 · Balance 3,126,427 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F3: The transaction was executed in multiple trades at prices ranging from $504.94 to $505.875. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 4 · 2026-09-08 · Sale · Disposed 744 · Balance 3,125,683 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F4: The transaction was executed in multiple trades at prices ranging from $505.95 to $506.885. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2026-09-08 · Sale · Disposed 749 · Balance 3,124,934 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F5: The transaction was executed in multiple trades at prices ranging from $506.96 to $507.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 6 · 2026-09-08 · Sale · Disposed 1,774 · Balance 3,123,160 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F6: The transaction was executed in multiple trades at prices ranging from $507.97 to $508.95. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 7 · 2026-09-08 · Sale · Disposed 1,319 · Balance 3,121,841 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F7: The transaction was executed in multiple trades at prices ranging from $508.985 to $509.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 8 · 2026-09-08 · Sale · Disposed 1,348 · Balance 3,120,493 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F8: The transaction was executed in multiple trades at prices ranging from $510.045 to $511.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 9 · 2026-09-08 · Sale · Disposed 1,251 · Balance 3,119,242 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F9: The transaction was executed in multiple trades at prices ranging from $511.045 to $511.985. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 10 · 2026-09-08 · Sale · Disposed 1,033 · Balance 3,118,209 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F10: The transaction was executed in multiple trades at prices ranging from $512.19 to $513.105. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 11 · 2026-09-08 · Sale · Disposed 197 · Balance 3,118,012 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025. F11: The transaction was executed in multiple trades at prices ranging from $513.23 to $513.645. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
F2: The transaction was executed in multiple trades at prices ranging from $503.46 to $504.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The transaction was executed in multiple trades at prices ranging from $504.94 to $505.875. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: The transaction was executed in multiple trades at prices ranging from $505.95 to $506.885. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: The transaction was executed in multiple trades at prices ranging from $506.96 to $507.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: The transaction was executed in multiple trades at prices ranging from $507.97 to $508.95. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7: The transaction was executed in multiple trades at prices ranging from $508.985 to $509.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8: The transaction was executed in multiple trades at prices ranging from $510.045 to $511.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9: The transaction was executed in multiple trades at prices ranging from $511.045 to $511.985. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10: The transaction was executed in multiple trades at prices ranging from $512.19 to $513.105. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11: The transaction was executed in multiple trades at prices ranging from $513.23 to $513.645. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Insight Molecular Diagnostics Inc.
Report date February 07, 2025 · Filed February 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, no par valueSEC Table I · non-derivative | IndirectSee footnote | 3,258,485 |
Last balance in matching sequence
After 2025-02-07 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-02-07 · Purchase · Acquired 1,077,600 · Balance 2,872,671 F1: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto. F2: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Row 2 · 2025-02-07 · Other · Acquired 385,814 · Balance 3,258,485 F3: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto. F2: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.
F2: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
F3: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 851 | $539.38 | $459,012.64 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 7 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,068,626 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F8 · price: The transaction was executed in multiple trades at prices ranging from $538.85 to $539.76. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 870 | $537.91 | $467,980.83 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 6 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,069,477 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F7 · price: The transaction was executed in multiple trades at prices ranging from $537.41 to $538.39. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 62 | $536.96 | $33,291.54 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 5 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,070,347 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F6 · price: The transaction was executed in multiple trades at prices ranging from $536.385 to $537.08. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 532 | $534.87 | $284,551.64 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 4 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,070,409 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F5 · price: The transaction was executed in multiple trades at prices ranging from $534.86 to $535.455. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 1,289 | $534.08 | $688,428.35 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 3 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,070,941 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F4 · price: The transaction was executed in multiple trades at prices ranging from $533.86 to $534.82. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 877 | $533.22 | $467,634.12 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,072,230 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F3 · price: The transaction was executed in multiple trades at prices ranging from $532.80 to $533.78. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:42 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 875 | $532.19 | $465,663.98 |
DisclosureSEC source: 0001069183-25-000063 · wk-form4_1745440920.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,073,107 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2024. F2 · price: The transaction was executed in multiple trades at prices ranging from $531.70 to $532.695. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 20:30 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GrantCommon Stock | 194,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001069183-25-000040 · wk-form4_1743021024.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,073,982 F1 · kind: The transaction consists of performance-based restricted stock units granted on December 22, 2023, for the achievement of tranches 1 and 2 of the 2024 CEO Performance Award, for which the performance conditions were determined to have been certified by the Compensation Committee on the transaction date. The units will vest on December 31, 2028, subject to continued employment through such date. Following the vesting of each tranche, the shares applicable to each tranche are subject to a minimum holding period from the vesting date until the earlier of (i) December 31, 2030 and (ii) the date that a subsequent tranche vests, excluding shares that are withheld to cover taxes. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | OtherCommon Stock, no par value | 385,814 | $2.05 | $790,918.70 |
DisclosureSEC source: 0001493152-25-005942 · ownership.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 3,258,485 F3 · shares: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a registered direct offering pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto. F2 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 1,077,600 | $2.05 | $2,209,080.00 |
DisclosureSEC source: 0001493152-25-005942 · ownership.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,872,671 F1 · shares: Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto. F2 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| February 04, 2025 Filed Feb 4, 2025 21:45 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 25 | $2.02 | $50.50 |
DisclosureSEC source: 0001493152-25-004871 · ownership.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,795,071 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:45 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 890 | $2.01 | $1,788.90 |
DisclosureSEC source: 0001493152-25-004871 · ownership.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,795,046 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| January 30, 2025 Filed Jan 31, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 318 | $2.01 | $639.18 |
DisclosureSEC source: 0001493152-25-004470 · ownership.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,794,156 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 3,880 | $2.01 | $7,798.80 |
DisclosureSEC source: 0001493152-25-004470 · ownership.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,793,838 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| January 14, 2025 Filed Jan 15, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 10,286 | $2.15 | $22,114.90 |
DisclosureSEC source: 0001493152-25-002410 · ownership.xml · nonDerivative · entry 3 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,789,958 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| January 14, 2025 Filed Jan 15, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 100 | $2.08 | $208.00 |
DisclosureSEC source: 0001493152-25-002410 · ownership.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,779,672 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| January 13, 2025 Filed Jan 15, 2025 22:00 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 5,669 | $2.08 | $11,791.52 |
DisclosureSEC source: 0001493152-25-002410 · ownership.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,779,572 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| December 26, 2024 Filed Dec 28, 2024 02:49 UTC | Insight Molecular Diagnostics Inc. OCX · Entity 6631 | PurchaseCommon Stock, no par value | 90,219 | $2.13 | $192,166.47 |
DisclosureSEC source: 0001493152-24-052334 · ownership.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,773,903 F1 · ownership.nature: The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 22:02 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GiftCommon Stock | 15,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029622 · form4-12172024_101218.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,879,952 F2 · kind: Represents a gift of shares to a donor advised fund. The reporting person has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 22:02 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | GiftCommon Stock | 29,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029622 · form4-12172024_101218.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,895,529 F1 · kind: Represents a gift to family trusts for which the reporting person is neither the beneficiary nor the trustee. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:26 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 298 | $405.70 | $120,900.03 |
DisclosureSEC source: 0001415889-24-024758 · form4-10042024_081059.xml · nonDerivative · entry 4 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,925,060 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F5 · price: The transaction was executed in multiple trades at prices ranging from $405.48 to $405.76. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:26 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 1,404 | $404.64 | $568,116.67 |
DisclosureSEC source: 0001415889-24-024758 · form4-10042024_081059.xml · nonDerivative · entry 3 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,925,358 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F4 · price: The transaction was executed in multiple trades at prices ranging from $404.23 to $405.16. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:26 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 2,460 | $403.94 | $993,690.68 |
DisclosureSEC source: 0001415889-24-024758 · form4-10042024_081059.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,926,762 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F3 · price: The transaction was executed in multiple trades at prices ranging from $403.22 to $404.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:26 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 605 | $403.04 | $243,837.20 |
DisclosureSEC source: 0001415889-24-024758 · form4-10042024_081059.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,929,222 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F2 · price: The transaction was executed in multiple trades at prices ranging from $402.20 to $403.19. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionEmployee Stock Option · Derivative | 58,965 | $0.00 Strike: $28.58 | $0.00 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · derivative · entry 15 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,931 Underlying: Common Stock · 58,965 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 3,738 | $405.22 | $1,514,718.34 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 12 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,929,827 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · price: The transaction was executed in multiple trades at prices ranging from $405.00 to $405.83. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 15,986 | $404.39 | $6,464,575.34 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 11 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,933,565 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F9 · price: The transaction was executed in multiple trades at prices ranging from $404.00 to $404.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 49,896 | $403.44 | $20,130,261.78 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 10 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,949,551 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F8 · price: The transaction was executed in multiple trades at prices ranging from $403.00 to $403.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 15,613 | $402.60 | $6,285,743.84 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 9 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,999,447 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F7 · price: The transaction was executed in multiple trades at prices ranging from $402.00 to $402.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 11,912 | $402.60 | $4,795,733.08 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 8 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,015,060 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F2 · kind: Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period. F7 · price: The transaction was executed in multiple trades at prices ranging from $402.00 to $402.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 2,373 | $401.66 | $953,138.47 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 7 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,026,972 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F2 · kind: Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period. F6 · price: The transaction was executed in multiple trades at prices ranging from $401.00 to $401.98. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 13,422 | $400.07 | $5,369,748.94 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 6 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,029,345 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F2 · kind: Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period. F5 · price: The transaction was executed in multiple trades at prices ranging from $400.00 to $400.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionCommon Stock | 58,965 | $404.51 | $23,851,932.15 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 5 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,042,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionEmployee Stock Option · Derivative | 100,917 | $0.00 Strike: $28.58 | $0.00 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · derivative · entry 14 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,896 Underlying: Common Stock · 100,917 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 47,314 | $400.07 | $18,928,997.15 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 4 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,983,802 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F2 · kind: Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period. F4 · price: The transaction was executed in multiple trades at prices ranging from $400.00 to $400.79. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionCommon Stock | 100,917 | $399.22 | $40,288,084.74 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 3 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,031,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionEmployee Stock Option · Derivative | 10,118 | $0.00 Strike: $28.58 | $0.00 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · derivative · entry 13 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,813 Underlying: Common Stock · 10,118 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 4,746 | $400.02 | $1,898,515.33 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 2 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,930,199 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F2 · kind: Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period. F3 · price: The transaction was executed in multiple trades at prices ranging from $400.00 to $400.07. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 30, 2024 Filed Oct 3, 2024 00:27 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionCommon Stock | 10,118 | $399.60 | $4,043,152.80 |
DisclosureSEC source: 0001415889-24-024538 · form4-10032024_121000.xml · nonDerivative · entry 1 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,934.945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 620 | $356.10 | $220,780.26 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 22 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,924,827 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F21 · price: The transaction was executed in multiple trades at prices ranging from $355.82 to $356.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 8,090 | $355.26 | $2,874,064.73 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 21 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,925,447 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F20 · price: The transaction was executed in multiple trades at prices ranging from $354.82 to $355.80. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 8,753 | $354.36 | $3,101,753.34 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 20 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,933,537 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F19 · price: The transaction was executed in multiple trades at prices ranging from $353.82 to $354.81. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 2,874 | $353.49 | $1,015,939.46 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 19 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,942,290 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F18 · price: The transaction was executed in multiple trades at prices ranging from $352.81 to $353.80. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 10,758 | $351.44 | $3,780,822.72 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 18 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,945,164 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F17 · price: The transaction was executed in multiple trades at prices ranging from $351.00 to $351.92. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 14,444 | $350.48 | $5,062,395.23 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 17 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,955,922 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F16 · price: The transaction was executed in multiple trades at prices ranging from $350.00 to $350.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | Exercise / conversionEmployee Stock Option · Derivative | 64,505 | $0.00 Strike: $28.58 | $0.00 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · derivative · entry 24 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,931 Underlying: Common Stock · 64,505 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 800 | $362.70 | $290,160.00 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 16 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,970,366 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 2,031 | $361.13 | $733,457.06 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 15 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,971,166 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F15 · price: The transaction was executed in multiple trades at prices ranging from $360.55 to $361.35. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 2,076 | $359.91 | $747,170.05 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 14 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,973,197 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F14 · price: The transaction was executed in multiple trades at prices ranging from $359.52 to $360.34. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 21:51 UTC | AXON ENTERPRISE, INC. AXON · Entity 567 | SaleCommon Stock | 7,289 | $358.87 | $2,615,820.92 |
DisclosureSEC source: 0001415889-24-022803 · form4-09042024_090930.xml · nonDerivative · entry 13 SMITH PATRICK W · CIK 0001167028 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,975,273 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F10 · kind: This sale of unrestricted shares was executed pursuant to a filed Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2024. F13 · price: The transaction was executed in multiple trades at prices ranging from $358.48 to $359.43. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.